x

Connexion

x

Inscription


Valider

CAPRELSA® (vandetanib) REMS Program | Advanced Medullary Thyroid Carcinoma (MTC)

Information for the CAPRELSA REMS Program. CAPRELSA® (vandetanib), a kinase inhibitor, approved by the FDA for symptomatic or progressive medullary thyroid cancer treatment in patients with unresectable locally advanced or metastatic disease.
Est-ce votre site ? Validez et mettez à jour les informations de votre site

VANDETANIBTOUCHPOINTS.COM sur les réseaux sociaux



WHOIS
Mettre en Favoris

Sites web relatifs

Cut the Rope 2
Cut the Rope 2
Tap The Frog
Tap The Frog
FRUIT SLOTS
FRUIT SLOTS
MEGA SLOTS
MEGA SLOTS
1941 FROZEN FRONT
1941 FROZEN FRONT
Cut the Rope
Cut the Rope